BELLORINI, Lorenzo,BERNAREGGI, Alberto,PIZZUTTI, Marco
申请号:
DK16154717
公开号:
DK3056187T3
申请日:
2012.11.13
申请国别(地区):
DK
年份:
2018
代理人:
摘要:
The present invention relates to a single-dose formulation for oral use of the thyroid hormones triiodothyronine or liothyronine (T3) and tetraiodothyronine or thyroxine (T4) in water-alcohol solution, which is physically and chemically stable, protected against accidental or microbiological contamination, in a container for pharmaceutical use which is squeezable and impermeable to the evaporation of the volatile substances it contains, and the corresponding means for implementing it.